Recommended Pages at astrazeneca-us.com
AstraZeneca to streamline US commercial business
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on October 6, 2011 at 8:08 pm By:
#AstraZeneca to cut 400 jobs in U.S. commercial biz. Asking for volunteers 1st http://t.co/FLTbThCW $AZN #pharma
BRILINTA™ (ticagrelor) tablets now available in U.S. pharmacies for patients with acute coronary syndrome
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on August 22, 2011 at 4:54 pm By:
eyeonfda Pharma and Health Lawyer
AZ's BRILINTA™ (ticagrelor) tablets now available in U.S. pharmacies for patients with acute #coronary syndrome http://ow.ly/69zLT
AstraZeneca announces trade name CAPRELSA® for vandetanib
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on August 1, 2011 at 6:22 pm By:
Vandetanib now has a brand name: Caprelsa (medullary thyroid cancer drug) http://t.co/EXqkAEk
KOMBIGLYZE™ XR (saxagliptin and metformin HCl extended-release) tablets approved in the U.S. for the treatment of type 2 diabetes mellitus in adults
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on November 5, 2010 at 5:21 pm By:
eyeonfda Pharma and Health Lawyer
AZ sez FDA approves KOMBIGLYZEâ„¢ XR (saxagliptin and metformin HCl extended-release) tablets for type 2 adult diabetes http://ow.ly/357wz
AstraZeneca recognized for eco-leadership - http://ow.ly/1SZoa
astrazeneca-us.com — “AstraZeneca recognized for eco-leadership - http://ow.ly/1SZoa” View full resource at astrazeneca-us.com
Most Recently Shared on June 2, 2010 at 1:10 pm By:
eyeonfda Pharma and Health Lawyer
AstraZeneca recognized for eco-leadership - http://ow.ly/1SZoa
AstraZeneca launches SEROQUEL XR® for add-on treatment of major depressive disorder
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on April 16, 2010 at 4:05 pm By:
eyeonfda Pharma and Health Lawyer
AZ launches SEROQUEL XR® (quetiapine fumarate) 4 add-on treatment of major depressive disorder http://ow.ly/1zn8x
@AstraZeneca outlines principles for product-related online communications (PDF): http://bit.ly/bfmYRa #hcsmeu
astrazeneca-us.com — “@AstraZeneca outlines principles for product-related online communications (PDF): http://bit.ly/bfmYRa #hcsmeu” View full resource at astrazeneca-us.com
Most Recently Shared on March 2, 2010 at 8:24 am By:
Len Starnes Pharma, Health Executive, Health Social Media, and Health Marketing
@andrewspong @AstraZeneca Principles & recommendations 4 product SM coms http://bit.ly/bfmYRa #hcsmeu 5 guiding principles good framework
Advisory Committee briefing materials for CRESTOR® sNDA available on US FDA web site
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on December 12, 2009 at 1:17 pm By:
eyeonfda Pharma and Health Lawyer
Advisory Committee briefing materials for CRESTOR® sNDA available on US FDA web site - http://ow.ly/Le8q
AstraZeneca News
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on December 11, 2009 at 12:38 am By:
eyeonfda Pharma and Health Lawyer
New AZ Phase3 data from CONFIRM study for FASLODEX® in breast cancer - http://ow.ly/KN75
SEROQUEL approved for the pediatric treatment of schizophrenia and bipolar mania
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on December 4, 2009 at 2:04 pm By:
eyeonfda Pharma and Health Lawyer
FDA approves SEROQUEL for the pediatric treatment of schizophrenia and bipolar mania - http://ow.ly/IxFQ
SEROQUEL XR® approved for add-on treatment of Major Depressive Disorder
astrazeneca-us.com — “Visit the AstraZeneca U.S. Corporate Web site (www.astrazeneca-us.com) for more information.” View full resource at astrazeneca-us.com
Most Recently Shared on December 4, 2009 at 2:03 pm By:
eyeonfda Pharma and Health Lawyer
FDA approves SEROQUEL XR® for add-on treatment of Major Depressive Disorder - http://ow.ly/IxE7
AZ and the Philadelphia Department of Public Health provide free medicines to PA’s uninsured
astrazeneca-us.com — “Learn how, with this program, AstraZeneca builds on its more than 30-year history of helping patients afford the medicines they need.” View full resource at astrazeneca-us.com
Most Recently Shared on November 20, 2009 at 4:04 pm By:
eyeonfda Pharma and Health Lawyer
Interesting model - AstraZ and the Philadelphia Dept of Pub Health provide free medicines to Pennsylvania’s uninsured - http://ow.ly/E3b1
New analysis shows SYMBICORT® improved airflow obstruction in patients with COPD
astrazeneca-us.com — “Learn how data also finds SYMBICORT achieved improvement in lung function within five minutes.” View full resource at astrazeneca-us.com
Most Recently Shared on November 9, 2009 at 4:16 pm By:
eyeonfda Pharma and Health Lawyer
New post-hoc, pooled analysis of SYMBICORT® data in COPD - http://ow.ly/AKg8
CRESTOR® approved for use in pediatric patients with HeFH
astrazeneca-us.com — “Read how the FDA decision was based on a supplemental New Drug Application submitted by AstraZeneca which included data from the PLUTO study.” View full resource at astrazeneca-us.com
Most Recently Shared on October 16, 2009 at 1:05 pm By:
eyeonfda Pharma and Health Lawyer
FDA approves CRESTOR® for use in pediatric patients with heterozygous familial hypercholesterolemia http://bit.ly/4aRRkt
AstraZeneca News
astrazeneca-us.com — “Learn how efficacy results were achieved with no increase in major bleeding.” View full resource at astrazeneca-us.com
Most Recently Shared on August 31, 2009 at 2:15 pm By:
eyeonfda Pharma and Health Lawyer
Phase III head to head ticagrelor over clopidogrel in acute coronary syndrome patients http://bit.ly/dExgg
